PAF-RECEPTOR .1. CACHE-OREILLES EFFECT OF SELECTED HIGH-POTENCY PLATELET-ACTIVATING FACTOR (PAF) ANTAGONISTS
- 1 July 1989
- journal article
- research article
- Vol. 1 (4) , 201-215
Abstract
Three-dimensional electrostatic maps were calculated for six potent antagonists of platelet-activating factor (PAF), the antagonists being selected for their apparent structural heterogeneity. The molecules examined were the compact Ginkgolides BN 52020, BN 52021 and BN 52022 (1, 2 and 3), the semi-rigid kadsurenone (4), a flexible synthetic dinor type C furanoid lignan L-652,731 (5a) and the triazolothienobenzodiazepine WEB 2086 (7). Calculation of the electrostatic potential generated around all of the above molecules showed the existence of two wells of negative potential or ''cache-oreilles'' (ear-muffs), i.e., the isocontours drawn at - 10 kcal/mol, located at 180.degree. from each other and separated by a maximum distance of 22-27 .ANG.. Except for the synthetic dinor type C furanoid lignan (5a), the molecules also presented a moderate hydrophobic fragment, which constitutes a third point of interaction with the high-affinity binding site in rabbit and human platelets. The findings of the present study allow speculation that this high-affinity acceptor site may be a ''polarized cylinder'' with a diameter of 10-12 .ANG.This publication has 8 references indexed in Scilit:
- Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activityJournal of Medicinal Chemistry, 1987
- Conformation and activity of tetrahydrofuran lignans and analogs as specific platelet-activating-factor antagonistsJournal of Medicinal Chemistry, 1986
- trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.Journal of Biological Chemistry, 1985
- Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.Proceedings of the National Academy of Sciences, 1985
- New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixturesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).Journal of Biological Chemistry, 1979
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979
- (2S,3S,3aS)-5-Allyl-3a-methoxy-2-(3',4',5'-trimethoxyphenyl)-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran (a neolignan: mirandin-A)Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1977